A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures DOI Open Access
Silvia Strocchi, Giacomo Santandrea, Eleonora Zanetti

и другие.

Cancers, Год журнала: 2024, Номер 17(1), С. 27 - 27

Опубликована: Дек. 25, 2024

Background/Objectives: Despite the introduction of innovative therapeutics, lung cancer is still leading cause cancer-related death. For this reason, requires deep characterization to identify cellular and molecular targets that can be used develop novel therapeutic strategies. Three-dimensional models, including patient-derived organoids (PDOs), represent useful tools study biology may employed in future as predictive decisions. However, successful establishment cultures faithfully respective patient tissues challenging due low success rate and/or overgrowth normal airway epithelial cells. Methods: We set up a two-step protocol allows for establishing both short-term long-term 3D cultures, with different characteristics rates. Results: Cancer tissue-originated spheroids (CTOSs) show 100% allow concomitant isolation autologous tumor infiltrating leukocytes (TILs). On contrary, PDOs expanded medium-long term bio-banked but retain lower possibility contamination To overcome these problems, we an optimal medium formulation implemented rigorous quality controls, substantial improvement tumoral PDO establishment. Conclusions: Overall, guarantees flexibility reliability, also providing guidelines control checks support experimental settings. The setting robust culture expansion key requirement their employment research clinical practice.

Язык: Английский

Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids DOI Creative Commons
Ruixin Yang,

Wingyan Kwan,

Yutong Du

и другие.

Cancer Letters, Год журнала: 2024, Номер 598, С. 217106 - 217106

Опубликована: Июль 9, 2024

Diffuse-type gastric cancer (DGC) is a subtype of with aggressiveness and poor prognosis. It great significance to find sensitive drugs for DGC. In the current study, total 20 patient-derived organoids (PDOs) were analyzed screening therapeutic efficacy small molecule kinases inhibitors on cancers, especially difference between intestinal-type (IGCs) DGCs. The IGCs are multiple inhibitors, while DGCs resistant most these inhibitors. was found that showed drug-induced senescent phenotype after treatment by aurora (AURKi) Barasertib-HQPA Danusertib. cell diameter cells increased stronger staining senescence-associated β-galactosidase (SA-β-GAL), characteristic appearance multinucleated giant cells. secrete large amounts chemokine MCP-1/CCL2, which recruit induce macrophage M2-type polarization in PDOs DGC (DPDOs)-macrophage co-culture system. up-regulation local MCP-1/CCL2 can interact receptor (CCR2) expressed macrophages suppress their innate immunity Overall, special response AURKi suggests clinicians should select sequential therapy clearance

Язык: Английский

Процитировано

6

Constructing Tumor Organoid-like Tissue for Reliable Drug Screening Using Liver-Decellularized Extracellular Matrix Scaffolds DOI Creative Commons
Zhoujiang Chen,

Lianlin Long,

Ji Wang

и другие.

ACS Omega, Год журнала: 2024, Номер unknown

Опубликована: Янв. 29, 2024

The interplay between cells and their microenvironments plays a pivotal role in

Язык: Английский

Процитировано

5

The Evolution of Technology‐Driven In Vitro Models for Neurodegenerative Diseases DOI Creative Commons
Eleonora De Vitis,

Antonella Stanzione,

Alessandro Romano

и другие.

Advanced Science, Год журнала: 2024, Номер 11(16)

Опубликована: Фев. 17, 2024

Abstract The alteration in the neural circuits of both central and peripheral nervous systems is closely related to onset neurodegenerative disorders (NDDs). Despite significant research efforts, knowledge regarding NDD pathological processes, development efficacious drugs are still limited due inability access reproduce components system its intricate microenvironment. 2D culture too simplistic accurately represent more complex dynamic situation cells vivo have therefore been surpassed by 3D systems. However, models suffer from various limitations that can be overcome employing two innovative technologies: organ‐on‐chip printing. In this review, an overview advantages shortcomings microfluidic platforms extracellular matrix‐like biomaterials will given. Then, combination microfluidics hydrogels as a new synergistic approach study analyzing latest advances brain‐on‐chip for explored.

Язык: Английский

Процитировано

5

Precision Medicine for Peritoneal Carcinomatosis—Current Advances in Organoid Drug Testing and Clinical Applicability DOI Creative Commons

Harleen Kaur,

Josephine A. Wright, Daniel L. Worthley

и другие.

Organoids, Год журнала: 2025, Номер 4(1), С. 2 - 2

Опубликована: Янв. 24, 2025

Peritoneal carcinomatosis from gastrointestinal tumours is considered a poor prognostic factor, with median overall survival of six to nine months in the absence intervention. The advent patient-derived organoid cultures (PDOs) has provided breakthrough personalised medicine, allowing researchers and clinicians model complexity heterogeneity individual vitro. PDOs hold great promise this field, as variations management peritoneal due differences method delivery chemotherapeutics, drug selection, exposure duration, tumour pathology make it impractical use single, standardised treatment regimen. We aim summarise methodologies limitations studies encapsulating organoids derived metastases encourage design considerations that may improve future clinical relevance, standardise protocols, address translational challenges personalising strategies.

Язык: Английский

Процитировано

0

“ Advancing Nephrogenetics: Utilizing Single-Cell RNA Sequencing and Organoid Models for Precision Kidney Disease Treatment” DOI

Mohanapriya C.D.,

Praveen Kumar Kochuthakidiyel Suresh

Current Pediatrics Reports, Год журнала: 2025, Номер 13(1)

Опубликована: Март 17, 2025

Язык: Английский

Процитировано

0

Insights into targeting cellular senescence with senolytic therapy: The journey from preclinical trials to clinical practice DOI
Peng Chen,

Yulai Wang,

Benhong Zhou

и другие.

Mechanisms of Ageing and Development, Год журнала: 2024, Номер 218, С. 111918 - 111918

Опубликована: Фев. 23, 2024

Язык: Английский

Процитировано

3

Interleukin 13 Promotes Maturation and Proliferation in Metaplastic Gastroids DOI Creative Commons

Ela W. Contreras-Panta,

Su-Hyung Lee,

Yoonkyung Won

и другие.

Cellular and Molecular Gastroenterology and Hepatology, Год журнала: 2024, Номер 18(3), С. 101366 - 101366

Опубликована: Янв. 1, 2024

Type 2 innate lymphoid cells (ILC2s) and interleukin-13 (IL-13) promote the onset of spasmolytic polypeptide-expressing metaplasia (SPEM) cells. However, little is known about molecular effects IL-13 in SPEM We now sought to establish a reliable organoid model, Meta1 gastroids, model vitro. evaluated cellular ILC2s on maturation proliferation

Язык: Английский

Процитировано

3

Current advances in understanding endometrial epithelial cell biology and therapeutic applications for intrauterine adhesion DOI Creative Commons
Jia Wang, Hong Zhan, Y Wang

и другие.

Stem Cell Research & Therapy, Год журнала: 2024, Номер 15(1)

Опубликована: Окт. 25, 2024

The human endometrium is a highly regenerative tissue capable of undergoing scarless repair during the menstruation and postpartum phases. This process mediated by endometrial adult stem/progenitor cells. During healing injuries, swift reepithelization results in rapid covering wound surface facilitates subsequent restoration. involvement endogenous epithelial stem cells, stromal bone marrow-derived cells regeneration epithelium has been subject prolonged debate. Increasing evidence suggests that mainly relies on rather than Currently, no consensus established identity compartment. Several markers, including stage-specific embryonic antigen-1 (SSEA-1), sex-determining region Y-box 9 (SOX9), neural-cadherin (N-cadherin), leucine-rich-repeat-containing G-protein-coupled receptor 5 (LGR5), CD44, axis inhibition protein 2 (Axin2), aldehyde dehydrogenase 1A1 (ALDH1A1), have suggested as potential candidate markers for identification contributes to our understanding offers new therapeutic insights into diseases characterized defects endometrium, such intrauterine adhesion. review explores different perspectives origins mouse It summarizes locations, hierarchies both endometrium. also discusses cell-based treatments adhesion, hoping inspire further research clinical application

Язык: Английский

Процитировано

2

New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine DOI Creative Commons
Vittoria Rago, Anna Perri, Silvia Di Agostino

и другие.

Biomedicines, Год журнала: 2023, Номер 11(10), С. 2743 - 2743

Опубликована: Окт. 10, 2023

One of the major goals in advancement basic cancer research focuses on development new anticancer therapies. To understand molecular mechanisms progression, acquired drug resistance, and metastatic process, use preclinical vitro models that faithfully summarize properties tumor patients is still a necessity. The represented by diverse group cell clones, recent years, to reproduce models, monolayer cultures have been supplanted patient-derived xenograft (PDX) cultured organoids derived from patient (PDO). These proved indispensable for study microenvironment (TME) its interaction with cells. Prostate (PCa) most common neoplasia men world. It characterized genomic instability resistance conventional Despite advances diagnosis treatment, PCa remains leading cause death. Here, we review studies last 10 years as number papers growing very fast field. We also discuss discovered limitations challenges using organoid culture system PDXs studying prostate phenotype, performing testing, developing

Язык: Английский

Процитировано

4

Patient derived cancer organoids model the response to HER2-CD3 bispecific antibody (BsAbHER2) generated from hydroxyapatite gene delivery system DOI
Yuhong Liu, Chen Wang,

Guochuang Chen

и другие.

Cancer Letters, Год журнала: 2024, Номер 597, С. 217043 - 217043

Опубликована: Июнь 12, 2024

Язык: Английский

Процитировано

1